Engineering the microflora to vaccinate the mucosa:: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

被引:93
作者
Shaw, DM
Gaerthé, B
Leer, RJ
Van der Stap, JGMM
Smittenaar, C
Den Bak-Glashouwer, MJH
Thole, JER
Tielen, FJ
Pouwels, PH
Havenith, CEG
机构
[1] TNO Prevent & Hlth, Special Program Infect Dis, NL-2315 CE Leiden, Netherlands
[2] TNO Voeding, Dept Mol Genet & Gene Technol, Zeist, Netherlands
关键词
D O I
10.1046/j.1365-2567.2000.00069.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The delivery of antigens to mucosal-associated lymphoid tissues in paediatric and immunocompromised populations by safe, non-invasive vectors, such as commensal lactobacilli, represents a crucial improvement to prevailing vaccination options. In this report, we describe the oral and nasal immunization of mice with vaccines constructed through an original system for heterologous gene expression in Lactobacillus in which the 50 000-molecular weight (MW) fragment C of tetanus toxin (TTFC) is expressed either as an intracellular or a surface-exposed protein. Our data indicate that L. plantarum is more effective in this respect than L. casei and that, under the experimental conditions investigated, delivery of TTFC expressed as an intracellular antigen is more effective than cell-surface expression. Immunization of mice with live recombinant lactobacilli induced significant levels of circulating TTFC-specific immunoglobulin G (IgG) following nasal or oral delivery of vaccine strains. In addition, following nasal delivery, secretory immunoglobulin A (sIgA) was induced in bronchoalveolar lavage fluids, as were antigen-specific antibody-secreting cells and antigen-specific T-cell activation in draining lymph nodes, substantiating their potential for safe mucosal delivery of paediatric vaccines.
引用
收藏
页码:510 / 518
页数:9
相关论文
共 23 条
[1]   USE OF THE VIBRIO-CHOLERAE IRGA GENE AS A LOCUS FOR INSERTION AND EXPRESSION OF HETEROLOGOUS ANTIGENS IN CHOLERA VACCINE STRAINS [J].
BUTTERTON, JR ;
BOYKO, SA ;
CALDERWOOD, SB .
VACCINE, 1993, 11 (13) :1327-1335
[2]  
CLAASSEN E, 1994, RECOMBINANT SYNTHETI, P407
[3]  
CURTISS R, 1990, NEW GENERATION VACCI, P347
[4]   A SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY FOR ENUMERATION OF SPECIFIC ANTIBODY-SECRETING CELLS [J].
CZERKINSKY, CC ;
NILSSON, LA ;
NYGREN, H ;
OUCHTERLONY, O ;
TARKOWSKI, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) :109-121
[5]  
FERNANDES CF, 1987, FEMS MICROBIOL LETT, V46, P343, DOI 10.1111/j.1574-6968.1987.tb02471.x
[6]   ORAL-ADMINISTRATION OF TNP-LACTOBACILLUS CONJUGATES IN MICE - A MODEL FOR EVALUATION OF MUCOSAL AND SYSTEMIC IMMUNE-RESPONSES AND MEMORY FORMATION ELICITED BY TRANSFORMED LACTOBACILLI [J].
GERRITSE, K ;
POSNO, M ;
SCHELLEKENS, MM ;
BOERSMA, WJA ;
CLAASSEN, E .
RESEARCH IN MICROBIOLOGY, 1990, 141 (7-8) :955-962
[7]   CONSTRUCTION OF GENETICALLY DEFINED DOUBLE ARO MUTANTS OF SALMONELLA-TYPHI [J].
HONE, DM ;
HARRIS, AM ;
CHATFIELD, S ;
DOUGAN, G ;
LEVINE, MM .
VACCINE, 1991, 9 (11) :810-816
[8]   IMPROVED IMMUNOGENICITY OF ORAL DXRRV REASSORTANT ROTAVIRUS VACCINE BY LACTOBACILLUS-CASEI GG [J].
ISOLAURI, E ;
JOENSUU, J ;
SUOMALAINEN, H ;
LUOMALA, M ;
VESIKARI, T .
VACCINE, 1995, 13 (03) :310-312
[9]   Instruments for oral disease-intervention strategies:: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis [J].
Maassen, CBM ;
Laman, JD ;
den Bak-Glashouwer, MJH ;
Tielen, FJ ;
van Holten-Neelen, JCPA ;
Hoogteijling, L ;
Antonissen, C ;
Leer, RJ ;
Pouwels, PH ;
Boersma, WJA ;
Shaw, DM .
VACCINE, 1999, 17 (17) :2117-2128
[10]   No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice [J].
Marcotte, H ;
Lavoie, MC .
INFECTION AND IMMUNITY, 1996, 64 (11) :4694-4699